Published on 11 Dec 2021 on Insider Monkey via Yahoo Finance
Hedge Funds Never Been Less Bullish On Nabriva Therapeutics plc (NBRV)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out what the billionaire investors and hedge funds think of Nabriva Therapeutics plc (NASDAQ:NBRV).
Nabriva Therapeutics plc (NASDAQ:NBRV) investors should be aware of a decrease in hedge fund sentiment recently. Nabriva Therapeutics plc (NASDAQ:NBRV) was in 4 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic is 12. Our calculations also showed that NBRV isn't among the 30 most popular stocks among hedge funds (click for Q1 rankings).
Why do we pay any attention at all to hedge fund sentiment? Our research has shown that a select group of hedge fund holdings outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). That's why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.